Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Biosimilars represent a meaningful opportunity to reduce drug spending by as much as $375 billion over the next decade. Cigna is committed to driving greater value and lower costs where clinically appropriate for our customers and clients. As a longtime advocate for greater availability of biosimilars, we have worked for a decade to advance the pathways needed to bring biosimilars to market.
Aug 2, 2022 -
At Cigna Healthcare, our diabetes care solutions are built around a whole-person health strategy. The aim is to help identify, prevent and manage diabetes by connecting individuals to the right level of care. We look at some of the ways our approach has helped patients save money, and improves medication adherence and health outcomes.
Jul 28, 2022 -
Patients may not be aware that infusion centers are quality sites of care that are often more affordable options for receiving infusions for complex conditions such as cancer, rheumatoid arthritis, hemophilia, and hepatitis C.
Jun 9, 2022 -
When employers select health plan networks for their employees, they may look at the pure size of a network and assume the more doctors, hospitals, and clinics that are included, the better. However, size alone does not equal quality. The quality of care a patient receives is critical in managing the total cost of care, which includes medical, pharmacy, and behavioral care costs.
May 13, 2022 -
According to new research from AHIP, the cost to patients and their health plans is particularly high when specialty drugs are administered to patients in a hospital setting. The key finding: Specialty pharmacies are the more affordable option.
Mar 17, 2022